Clinical Trial Update: A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

This update notes the completion of a Phase 1 study evaluating Telitacicept in children with childhood-onset systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Telitacicept

Snippet

Sponsor: RemeGen Co., Ltd. | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: COMPLETED